We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Oryzon Nominates Specific LSD1 Inhibitor as Drug Candidate

News   May 24, 2012

 
Oryzon Nominates Specific LSD1 Inhibitor as Drug Candidate
 
 
Advertisement
 

RELATED ARTICLES

How Old Is Your Dog in Human Years? A New Method for Calculating

News

By mapping molecular changes in the genome over time, researchers have developed a formula to more accurately compare dog age to human age.

READ MORE

Safer and More Efficient Method To Deliver Gene Therapy

News

Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination.

READ MORE

Chemo Drug May Be Less Effective in Overweight Women With Breast Cancer

News

Breast cancer patients who are overweight or obese might benefit less from treatment with a common chemotherapy drug, called docetaxel.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE